BIOMAT Database Logo BIOMAT Database Logo

[Therapeutic trial of a new antidiabetic with vascular action: 1702 SE]. 1972

J Jaillard, and H Warembourg

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013453 Sulfonylurea Compounds A class of compounds in which a sulfone functional group is attached to UREA. Compounds, Sulfonylurea

Related Publications

J Jaillard, and H Warembourg
[Therapeutic value of a new original oral antidiabetic with vascular action: gliclazide (SE-1702)].
January 1972, Therapeutique (La Semaine des hopitaux),
J Jaillard, and H Warembourg
[Therapeutic trial of a new neuroleptic with prolonged action, pimozide].
April 1970, Annales medico-psychologiques,
J Jaillard, and H Warembourg
[TRIAL OF A NEW ORAL ANTIDIABETIC].
June 1964, Wiener medizinische Wochenschrift (1946),
J Jaillard, and H Warembourg
The pharmacology of S 1702, a new highly effective oral antidiabetic drug with unusual properties. 2. Protective activity of S 1702 on the microvascular system in normal and diabetic rats.
October 1972, Arzneimittel-Forschung,
J Jaillard, and H Warembourg
[New sulfonamides with uricosuric, diuretic & antidiabetic action].
January 1957, Revue medicale du Moyen-Orient,
J Jaillard, and H Warembourg
[Gliclazide, a new antidiabetic with hemobiologic and vascular properties].
October 1972, Lyon medical,
J Jaillard, and H Warembourg
[Pharmacological action of a new oral antidiabetic drug].
January 1956, Bollettino della Societa italiana di biologia sperimentale,
J Jaillard, and H Warembourg
A clinical trial with glycodiazine--a new oral antidiabetic compound.
February 1970, Indian journal of medical sciences,
J Jaillard, and H Warembourg
TRIAL OF A NEW ORAL ANTIDIABETIC DRUG--GLYCODIAZINE.
June 1965, Journal of the Irish Medical Association,
J Jaillard, and H Warembourg
[Clinical trial of a new oral antidiabetic: glypizide].
January 1974, Revista iberica de endocrinologia,
Copied contents to your clipboard!